H Suzuki, H Uemura, A Mizokami, N Hayashi… - Cancer …, 2019 - Wiley Online Library
This open‐label, phase I dose‐finding study evaluated the gonadotropin‐releasing hormone
antagonist, TAK‐385, in Japanese patients with nonmetastatic prostate cancer. In a two‐part …